A supercharged HIV vaccine could offer strong protection with just one injection, a study in mice has indicated.. Developed by researchers from the Massachusetts Institute of Technology (MIT) and , ScienceDaily reports: Researchers from MIT and Scripps have unveiled a promising new HIV vaccine approach that generates a powerful immune response with just one dose.By combining two immune-boosting adjuvants alum and SMNP the vaccine lingers in lymph nodes for nearly a month, encouraging the body to produce a vast array of antibodies., Researchers at MIT and the Scripps Research Institute have shown that they can generate a strong immune response to HIV with just one vaccine dose, by adding two powerful adjuvants — materials that help stimulate the immune system. In a study of mice, the researchers showed that this approach… Click here to view the original […], Researchers at MIT and the Scripps Research Institute have shown that they can generate a strong immune response to HIV with just one vaccine dose, by adding two powerful adjuvants — materials that help stimulate the immune system.In a study of mice, the researchers showed that this approach produced a much wider diversity of antibodies against an HIV antigen, compared to the vaccine given , Researchers from MIT and the Scripps Research Institute have unveiled a potent vaccine strategy capable of generating a robust immune defense against HIV with just a single dose. By fusing two powerful immune-boosting agents known as adjuvants, scientists have paved the way for a potentially game-changing leap in vaccine technology., .